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  EVIDENCE-BASED ANSWER 
Standardized clinical decision rules, such as the Centor criteria, can identify patients with low likelihood of 
group A beta-hemolytic streptococ-cal (GABHS) pharyngitis who require no further evaluation or antibiotics 
(strength of recommendation [SOR]: A, based on validated cohort studies). For patients at intermediate and 
higher risk by clinical prediction rules, a positive rapid anti-gen detection (RAD) test is highly specific for 
GABHS (SOR: A, based on systematic reviews of diagnostic trials). 
A negative RAD test result, using the best technique, approaches the sensitivity of throat culture (SOR: B, 
based on retrospective cohort studies). In children and populations with an increased prevalence of GABHS 
and GABHS complications, adding a backup throat culture reduces the risk of missing GABHS due to false-
negative RAD results (SOR: C, based on expert opinion). 
  EVIDENCE SUMMARY 
In the US, GABHS is the cause of acute pharyn-gitis in 5% to 10% of adults and 15% to 30% of children. It is 
the only commonly occurring cause of pharyngitis with an indication for antibiotic therapy.1 The main benefit of 
antibiotic treatment in adults is earlier symptom relief—1 fewer day of fever and pain if antibiotics are begun 
within 3 days of onset. 
Antibiotic treatment also reduces the incidence of acute rheumatic fever, which complicates 1 case per 
100,000 in most of the US and Europe (relative risk reduction [RRR]=0.28).2 The risk of acute rheumatic fever 
is higher in some populaHawaiians (13–45 per 100,000).3 Treatment may also reduce suppurative 
complications (peritonsil-tions, particularly Native Americans and lar or retropharyngeal abscess), which occur 
in 1 case out of 1000.2,4 
A systematic review of the diagnosis of GABHS evaluated the accuracy of history and physical exam 
elements.5 Clinical prediction rules based on selected symptoms and signs can identify patients at low risk for 
GABHS. The 4 Centor criteria (history of fever, anterior cervical adenopathy, tonsillar exudates, absence of 
cough) are well validated in adult populations ( Table 1 ), while other clinical prediction rules (such as McIssac) 
are validated in populations with children and adults ( Table 2 ). The number of criteria present determines the 
likelihood ratio (LR), with which to calculate the posttest probability of GABHS. 
The usefulness of clinical prediction rules depends on knowing how prevalent GABHS is among cases of 
pharyngitis in a particular community. In a typical US adult population, GABHS comprises 5% to 10% of cases. 
The presence of only 1 Centor criterion would reduce the probability of GABHS pharyngitis to 2% to 3%, while 
meeting all 4 criteria would raise the probability to 25% to 40%, an intermediate value ( Table 1 ). If the 
prevalence of GABHS pharyngitis were 50%, as in some Native communities in Alaska, meeting all 4 criteria 
would predict an 86% probability of pharyngitis due to GABHS. Performing additional testing for patients with 
intermediate or high probability based on clinical prediction rules reduces the likelihood of unnecessary 
antibiotic treatment.1 
A systematic review6 of RAD testing demonstrates that the newer techniques (optical immunoassay, 
chemiluminescent DNA probes) have a sensitivity of 80% to 90%, which compares closely with that of throat 
culture (90%–95%). Both have a specificity greater than 95%, so false-positive test results are uncommon 
(LR+ =16–19). Treatment based on a positive RAD test would result in few unnecessary antibiotic 
prescriptions.1 
A retrospective outcome study4 reviewed the frequency of suppurative complications of GABHS among 30,036 
patients with pharyngitis diagnosed with either RAD testing or throat culture. Patients included adults and 
children in a primary care setting. Complication rates were identical. A prospective study of 465 suburban 
outpatients with pharyngitis assessed the accuracy of RAD diagnosis using throat culture as a reference. The 
RAD accuracy was 93% for pediatric patients and 97% for adults.5 In another retrospective review of RAD 
testing, investigators performed 11,427 RAD tests over 3 years in a private pediatric group. There were 8385 
negative tests, among which follow-up cultures detected 200 (2.4%) that were positive for GABHS. In the 
second half of the study, a newer RAD test produced a false-negative rate of 1.4%.7 Because of the possibility 
of higher false-negative RAD test rates in some settings, unless the physician has ascertained that RAD testing 
is comparable to throat culture in their own setting, expert opinion recommends confirming a negative RAD test 
in children or adolescents with a throat culture.1 Patients at higher risk of GABHS or GABHS complications 
may also warrant throat culture back up of RAD testing.1 
 
TABLE 1 
Centor clinical prediction rules for diagnosis of GABHS (for adults) 
One point for each: History of fever, anterior cervical adenopathy, tonsillar exudates, absence of cough 
Points LR+ Pretest prevalence of GABHS (%) 
   5 10 25 50 
   Post-test probability of GABHS (%) 
0 0.16 1 2 5 14 
1 0.3 2 3 9 23 
2 0.75 4 8 20 43 
3 2.1 10 19 41 68 
4 6.3 25 41 68 86 
GABHS, group A beta-hemolytic streptococcus; LR+, positive likelihood ratio. 
Adapted from data in Ebell et al 2000.5 
 
TABLE 2 
McIssac clinical prediction rules for diagnosis of GABHS (for adults and 
children) 
One point for each: History of fever (or measured temperature >38°C), absence of cough, tender anterior 
cervical adenopathy, tonsillar swelling or exudates, age <15. Subtract 1 point if age 45 or more 
Points LR+ Pretest prevalence of GABHS (%) 
   5 10 25 50 
   Post-test probability of GABHS (%) 
–1 or 0 0.05 <1 1 2 5 
1 0.52 3 5 15 33 
2 0.95 5 10 24 47 
3 2.5 12 22 45 56 
4 or 5 4.9 20 35 62 71 
GABHS, group A beta-hemolytic streptococcus; LR+, positive likelihood ratio. 
Adapted from data in Ebell et al 2000.5 
  RECOMMENDATIONS FROM OTHERS 
The Infectious Diseases Society of America recommends that if the physician is unable to exclude the 
diagnosis of GABHS on epidemiological or clinical grounds, either RAD testing or throat culture should be 
done. A positive result warrants treatment for patients with signs and symptoms of acute pharyngitis. A 
negative RAD result for a child or adolescent should be confirmed by throat culture unless the physician has 
ascertained that the sensitivity of RAD testing and throat culture are comparable in his or her practice setting.1 
The American Academy of Pediatrics also recommends laboratory confirmation of GABHS pharyngitis in 
children with throat culture or RAD testing. If a patient suspected clinically of GABHS has a negative RAD test, 
a throat culture should be done. Since some experts believe RAD tests using optical immunoassay are 
sufficiently sensitive to be used without throat culture backup, physicians who wish to use them should validate 
them by comparison to throat culture in their practice.8 
Clinical commentary 
The RAD test helps to avoid overprescribing antibiotics 
 
Peter  Danis,  MD 
St. John’s Mercy Medical Center, St. Louis, Mo 
The patient with a sore throat presents a diagnostic dilemma at 8:00 in the evening or on a Sunday 
morning. Patients (or parents) want something done, and frequently request antibiotics. Most of the 
time, they appreciate accurate information on the likelihood of a sore throat being a “strep throat” 
and the benefit or lack of benefit of antibiotics. The “in-between” cases are the toughest to manage, 
and the RAD test gives us the additional information needed to avoid overprescribing antibiotics. 
Empathetic reassurance and symptomatic treatment still suffice in most cases. 
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